National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Hepatitis C virus (HCV) infection contributes significantly to morbidity and mortality worldwide, is a prominent cause of chronic liver disease, and is the most prevalent reason for adult US residents to get a liver transplant. The aim of the study is to carry out a preliminary study on the prevalence of hepatitis C virus (HCV) among health care providers. A total of 100 blood sample were collected intravenously using sterile disposable needles and syringes into clean dry test tubes, allowed to clot, then centrifuged and the serum separated into dry plain containers. The serum was screened for hepatic C – antibody using the immunodiagnostic HCV spot card. The results revealed that health care providers within the age of 18 – 27 years were reported to have contacted the hepatitis C virus with having HCV of 6, this was followed by those within the age range of 28 – 37. The least value was recorded for health care providers within the age range of 48 – 57 years. The results show that the prevalence of HCV among health care providers within the age range of 18 – 27 and 28 – 37 years revealed a percentage prevalence of 8.33% and 6.67% respectively. According to the study, there is a significantly high prevalence of HCV infection among teenagers and adult health care providers within the age range of 18 - 27 and 28 - 37 years old, respectively.
Alter, H. J. and Houghton, M. (2000). Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Natural Medicine, 6: 1082-1086 https://doi.org/10.1038/80394
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L. and Alter, M. J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through. Annals of Internal Medicine, 144: 705-714 https://doi.org/10.7326/0003-4819-144-10-200605160-00004
Azeez-Akande, O., Sarki, A., Wokedi, E. E., Olabode, A. and Alabi, P. (2010). Sero-prevalence and risk factors of hepatitis C virus in patients and blood donors in Kano, Nigeria. Afr J Cln Exper Microbiol 11: 170-173. https://doi.org/10.4314/ajcem.v11i3.57775
Chan, K. and Mangla, N. (2022). Prevalence and risk factors of hepatitis C virus infection in the rural northeastern United States.Annals of Hepatology, 27: 100576. https://doi.org/10.1016/j.aohep.2021.100576
Chowdhury, A., Santra, A., Chaudhuri, S., Dhali, G. K., Chaudhuri, S., Maity, S. G., Naik, T. N., Bhattacharya, S. K. and Mazumder, D. N. (2003). Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology, 37: 802-809. https://doi.org/10.1053/jhep.2003.50157
Danaei G., Finucane M. M., Lu Y.,. 2011. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. The Lancet. 378(9785):31–40. https://doi.org/10.1016/s0140-6736(11)60679-x
Dubuisson, J. (2007). Hepatitis C virus proteins. World Journal of Gastroenterology, 13: 2406-2415. https://doi.org/10.3748/wjg.v13.i17.2406
Esan, A., Omisakin, C. T., Ojo-Bola, T., Owoseni, M., Fasakin K. and Ogunleye A. (2014). Sero-prevalence of hepatitis B and Hepatitis C virus co-infection among pregnant women in Nigeria. American Journal of Biomedical Research, 2(1):11-15. https://doi.org/10.12691/ajbr-2-1-3
Gogos, C. A., Fouka, K. P., Nikiforidis, G., Avgeridis, K., Sakellaropoulos, G., Bassaris, H., Maniatis, A. and Skoutelis, A. (2003). Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. European Journal of Epidemiology, 18: 551-557 https://doi.org/10.1023/a:1024698715741
Isaac, W. E., Ajani, A., Jalo, I., Alkali, Y., Oyeniyi, C., Okolie, H., Saidu, A., Jibrin, B., Aremu, J., Kudi, A., Danlami, H. and Charanchi, M. (2019). Hepatitis C in Adults and Children: A Cross-Sectional Review from a Tertiary Hospital, Northeast Nigeria during the Period 2008-2015. Journal of Infectious Disease Epidemiology, 5:096. https://doi.org/10.23937/2474-3658/1510096
Karoney, M. J. and Siika, A. M. (2013). Hepatitis C virus (HCV) infection in Africa: A review. Pan African Medical Journal, 14: 44. https://doi.org/10.11604/pamj.2013.14.44.2199
Kateera, F., Walker, T. D., Mutesa, L., Mutabazi, V., Musabeyesu, E., Mukabatsinda, C., Bihizimana, P., Kyamanywa, P., Karenzi, B. and Orikiiriza, J. T. (2015). Hepatitis B and seroprevalence among health care workers in a tertiary hospital in Rwanda. Transaction of the Royal Society of Tropical Medicine & Hygiene, 109(3):203-208. https://doi.org/10.1093/trstmh/trv004
Khan, U. R., Janjua, N. Z., Akhtar, S. and Hatcher, J. (2008a). Case-control study of risk factors associated with hepatitis C virus infection among pregnant women in hospitals of Karachi-Pakistan. Tropical Medicine & International Health, 13: 754-761 https://doi.org/10.1111/j.1365-3156.2008.02075.x
Lee, M-H., Yang, H-I., Yuan, Y., L'Italien, G. and Chen, C-J. (2014). Epidemiology and natural history of hepatitis C virus infection. World Journal of Gastroenterology, 20(28): 9270-9280. https://doi.org/10.3748/wjg.v20.i28.9270
Lingala, S. and Ghany, M. G. (2015). Natural history of hepatitis C. Gastroenterology Clinics of North America, 44(4):717–34. https://doi.org/10.1016/j.gtc.2015.07.003
Madhava, V., Burgess, C. and Drucker, E. (2002). Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infectious Diseases, 2: 293-302 https://doi.org/10.1016/s1473-3099(02)00264-5
Memon, M.I. and Memon, M.A. (2002) Hepatitis C: An Epidemiological Review. Journal of Viral Hepatitis, 9, 84-100. http://dx.doi.org/10.1046/j.1365-2893.2002.00329.x
Musa, B. M., Bussell, S., Borodo, M. M., Samaila, A. A. and Femi, O. L. (2015). Prevalence of Hepatitis B virus infection in Nigeria, 2000 - 2013: A systematic review and meta-analysis. Nigerian Journal of Clinical Practice, 18(2):163-172. https://doi.org/10.4103/1119-3077.151035
Nwokedi, E. E., Ilyasu, Z., Emokpae, A. I., Dutse, A. I. and Taura, A. A. (2006). Hepatitis C Virus infection among Teaching Hospital Patients in Kano, Nigeria: A Retrospective study. Annals of African Medicine, 5: 185-187.
Okayama, A., Stuver, S. O., Tabor, E., Tachibana, N., Kohara, M., Mueller, N. E. and Tsubouchi, H. (2002). Incident hepatitis C virus infection in a community-based population in Japan. Journal of Viral Hepatitis, 9: 43-51. https://doi.org/10.1046/j.1365-2893.2002.00331.x
Padua, L. T. and Jhaveri, R. (2016). Hepatitis C mother-to-child transmission. Neo Reviews, 17: e521-e531. https://doi.org/10.1542/neo.17-9-e521
Pérez, C. M., Suárez, E., Torres, E. A., Román, K. and Colón, V. (2005). Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico. International Journal of Epidemiology, 34: 593-599 https://doi.org/10.1093/ije/dyi059
Polaris Observatory HCV Collaborators (2017) Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterology& Hepatology, 2: 161-176. https://doi.org/10.1016/S2468-1253(16)30181-9
Posta, J., Ratnarajahc, S. and Lloyd, A. R. (2008). Immunological determinants of the outcomes from primary hepatitis C infection. Cellular & Molecular Life Science, 66(5): 733-56. https://doi.org/10.1007/s00018-008-8270-4
Roman, F., Hawotte, K., Struck, D., Ternes, A. M., Servaiss, J. Y., Arendt, V., Hoffman, P., Hemmer, R., Steub, T., Seguin-Devaux, C. and Schmit, J. C. (2008). Hepatatis C virus genotype distribution and transmition risk factors in luxembourg from 1991 to 2006. WJG; ISSN 1007-9327. https://doi.org/10.3748/wjg.14.1237
Simmonds P (2004). Genetic diversity and evolution of hepatitis C virus–15 years on. Journal of Genetic Virology, 85: 3173 - 3188. https://doi.org/10.1099/vir.0.80401-0
Sonderup, M. W., Afihene, M., Ally, R., Apica, A., Awuku, Y., Cunha, L., Dusheiko, G., Gogela, N., Lohouès-Kouacou, M. J., Lam, P., Lesi, O., Mbaye, P. S., Musabeyezu, E., Musau, B., Ojo, O., Rwegasha, J., Scholz, B., Shewaye, A. B., Tzeuton, C. and Kassianides, C. (2017). Hepatitis C in sub-Saharan Africa: The current status and recommendations for achieving elimination by 2030. Lancet Gastoenterology & Hepatology 2: 910-919.
Tagny, C. T., Mbanya, D., Tapko, J. B. and Lefrère, J. J. (2008). Blood safety in Sub-Saharan Africa: a multi-factorial problem. Transfusion, 48: 1256-1261 https://doi.org/10.1111/j.1537-2995.2008.01697.x
World Health Organisation (2016). Global health sector strategy on viral hepatitis, 2016-2021: Towards’ ending viral hepatitis.
World Health Organisation (2017). Global hepatitis report, 2017.
Ya’aba, Y., Isu, N.R., Onoja, A.J., Ibrahim, K., Mohammed, S.B. and Oladosu, P. (2015). Prevalence of Hepatitis C Virus (HCV) in Healthy Adults and Human Immunodeficiency Virus (HIV) infected persons in Abuja, Nigeria. Journal Phytomedicine and Therapeutics, 1: 11-23.
Citations |
 |
 |
 |
 |
